Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 281-290 of 682 for cancer

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Study To Compare Two Surgical Procedures In Women With BRCA1 Mutations To Assess Reduced Risk Of Ovarian Cancer

    Rochester, MN

  2. Differences In Immunological Effects Of Vitamin D Replacement Among African American Prostate Cancer Patients With Localized Versus Metastatic Disease

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  3. Safety And Efficacy Study Of TX103 CAR-T Cell Therapy For Recurrent Or Progressive Grade 4 Glioma.

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. Reduced Dose Hypofractionated Radiotherapy For Indolent Non-hodgkin Lymphoma

    Albert Lea, MN, Scottsdale/Phoenix, AZ, Eau Claire, WI, Jacksonville, FL, La Crosse, WI, Mankato, MN, Rochester, MN

  5. A Study Of ABBV-383 With Relapsed Refractory Waldenström Macroglobulinemia

    Rochester, MN

  6. A Master Protocol To Evaluate DCC-3009 In Gastrointestinal Stromal Tumor (GIST)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. Ivosidenib In Participants With Locally Advanced Or Metastatic Conventional Chondrosarcoma Untreated Or Previously Treated With 1 Systemic Treatment Regimen

    Jacksonville, FL, Rochester, MN

  8. A Study To Compare Standard Chemotherapy To Therapy With CPX-351 And/or Gilteritinib To To Treat Newly-diagnosed AML With Or Without FLT3 Mutations

    Rochester, MN

  9. Thoracotomy Versus Thoracoscopic Management Of Pulmonary Metastases In Patients With Osteosarcoma

    Rochester, MN

  10. A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin Lymphoma

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer